Submission Details
| 510(k) Number | K162390 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 26, 2016 |
| Decision Date | January 30, 2017 |
| Days to Decision | 157 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
K162390 is an FDA 510(k) clearance for the ET Hybrid Abutment, a Abutment, Implant, Dental, Endosseous (Class II — Special Controls, product code NHA), submitted by Hiossen, Inc. (Fariless Hills, US). The FDA issued a Cleared decision on January 30, 2017, 157 days after receiving the submission on August 26, 2016. This device falls under the Dental review panel. Regulated under 21 CFR 872.3630.
| 510(k) Number | K162390 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 26, 2016 |
| Decision Date | January 30, 2017 |
| Days to Decision | 157 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
| Product Code | NHA — Abutment, Implant, Dental, Endosseous |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 872.3630 |
| Definition | To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation. |